{"name":"Amsterdam UMC, location VUmc","slug":"amsterdam-umc-location-vumc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":15,"colorKey":"immunology","drugs":[{"name":"Aminobiphosphonate","genericName":"Aminobiphosphonate","slug":"aminobiphosphonate","indication":"Other","status":"phase_1"},{"name":"Discontinuation of imipenem-cilastatin or meropenem","genericName":"Discontinuation of imipenem-cilastatin or meropenem","slug":"discontinuation-of-imipenem-cilastatin-or-meropenem","indication":"Other","status":"marketed"},{"name":"Inotropes","genericName":"Inotropes","slug":"inotropes","indication":"Other","status":"marketed"},{"name":"Intrathecal Baclofen Pump","genericName":"Intrathecal Baclofen Pump","slug":"intrathecal-baclofen-pump","indication":"Spasticity","status":"phase_2"},{"name":"Psyllium Orange","genericName":"Psyllium Orange","slug":"psyllium-orange","indication":"Constipation relief","status":"marketed"},{"name":"Standard interval dosing","genericName":"Standard interval dosing","slug":"standard-interval-dosing","indication":"Other","status":"marketed"},{"name":"dexamethason","genericName":"dexamethason","slug":"dexamethason","indication":"Other","status":"marketed"},{"name":"ertugliflozine","genericName":"ertugliflozine","slug":"ertugliflozine","indication":"Other","status":"marketed"},{"name":"Benzbromaron","genericName":"Benzbromaron","slug":"benzbromaron","indication":"Gout","status":"marketed"},{"name":"Change in daily dosage of Growth Hormone","genericName":"Change in daily dosage of Growth Hormone","slug":"change-in-daily-dosage-of-growth-hormone","indication":"Growth hormone deficiency in children","status":"marketed"},{"name":"Ferricarboxymaltose","genericName":"Ferricarboxymaltose","slug":"ferricarboxymaltose","indication":"Other","status":"marketed"},{"name":"GnRHa","genericName":"GnRHa","slug":"gnrha","indication":"Other","status":"marketed"},{"name":"Macrogol Only Product in Oral Dose Form","genericName":"Macrogol Only Product in Oral Dose Form","slug":"macrogol-only-product-in-oral-dose-form","indication":"Constipation (chronic and acute)","status":"marketed"},{"name":"Magnesium hydroxide 724mg","genericName":"Magnesium hydroxide 724mg","slug":"magnesium-hydroxide-724mg","indication":"Other","status":"marketed"},{"name":"Prednisolone and Exenatide","genericName":"Prednisolone and Exenatide","slug":"prednisolone-and-exenatide","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"AZD0530 Difumarate","genericName":"AZD0530 Difumarate","slug":"azd0530-difumarate","indication":"Advanced solid tumors (Phase 2 investigational)","status":"phase_2"},{"name":"Afatinib, Osimertinib, Carboplatin and Pemetrexed","genericName":"Afatinib, Osimertinib, Carboplatin and Pemetrexed","slug":"afatinib-osimertinib-carboplatin-and-pemetrexed","indication":"Non-small cell lung cancer, Squamous non-small cell lung cancer, Non-small cell lung cancer with EGFR exon 19 deletion or exon 21 L858R mutation","status":"phase_2"},{"name":"Lipiodol UltraFluid","genericName":"Lipiodol UltraFluid","slug":"lipiodol-ultrafluid","indication":"Hepatocellular carcinoma (diagnostic imaging and transarterial chemoembolization)","status":"marketed"},{"name":"Radium-223 chloride","genericName":"Radium-223 chloride","slug":"radium-223-chloride","indication":"Metastatic castration-resistant prostate cancer with symptomatic bone metastases","status":"phase_3"},{"name":"Rhenium-188-HEDP","genericName":"Rhenium-188-HEDP","slug":"rhenium-188-hedp","indication":"Metastatic bone pain from osteoblastic bone lesions","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"Lopinavir/ritonavir + nevirapine","genericName":"Lopinavir/ritonavir + nevirapine","slug":"lopinavir-ritonavir-nevirapine","indication":"HIV-1 infection","status":"marketed"},{"name":"Lopinavir/ritonavir + zidovudine + lamivudine","genericName":"Lopinavir/ritonavir + zidovudine + lamivudine","slug":"lopinavir-ritonavir-zidovudine-lamivudine","indication":"HIV-1 infection","status":"marketed"}]},{"name":"Metabolic","slug":"metabolic","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Exenatide infusion","genericName":"Exenatide infusion","slug":"exenatide-infusion","indication":"Type 2 diabetes mellitus (investigational infusion formulation)","status":"phase_3"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"infectious","drugs":[{"name":"Placebo (for rivastigmine)","genericName":"Placebo (for rivastigmine)","slug":"placebo-for-rivastigmine","indication":"Control arm in rivastigmine clinical trials (Alzheimer's disease, Parkinson's disease dementia, or Lewy body dementia)","status":"marketed"}]}],"pipeline":[{"name":"AZD0530 Difumarate","genericName":"AZD0530 Difumarate","slug":"azd0530-difumarate","phase":"phase_2","mechanism":"AZD0530 is a Src family kinase inhibitor that blocks intracellular signaling pathways involved in cell proliferation and survival.","indications":["Advanced solid tumors (Phase 2 investigational)"],"catalyst":""},{"name":"Afatinib, Osimertinib, Carboplatin and Pemetrexed","genericName":"Afatinib, Osimertinib, Carboplatin and Pemetrexed","slug":"afatinib-osimertinib-carboplatin-and-pemetrexed","phase":"phase_2","mechanism":"Afatinib and Osimertinib are irreversible tyrosine kinase inhibitors targeting the epidermal growth factor receptor (EGFR), while Carboplatin is a platinum-based chemotherapy drug that works by crosslinking DNA, and Pemetrexed is an antifolate drug that inhibits thymidylate synthase.","indications":["Non-small cell lung cancer, Squamous non-small cell lung cancer, Non-small cell lung cancer with EGFR exon 19 deletion or exon 21 L858R mutation","Malignant pleural mesothelioma"],"catalyst":""},{"name":"Aminobiphosphonate","genericName":"Aminobiphosphonate","slug":"aminobiphosphonate","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Discontinuation of imipenem-cilastatin or meropenem","genericName":"Discontinuation of imipenem-cilastatin or meropenem","slug":"discontinuation-of-imipenem-cilastatin-or-meropenem","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Inotropes","genericName":"Inotropes","slug":"inotropes","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Intrathecal Baclofen Pump","genericName":"Intrathecal Baclofen Pump","slug":"intrathecal-baclofen-pump","phase":"phase_2","mechanism":"GABA_B receptor agonist","indications":["Spasticity"],"catalyst":""},{"name":"Psyllium Orange","genericName":"Psyllium Orange","slug":"psyllium-orange","phase":"marketed","mechanism":"Psyllium is a soluble dietary fiber that absorbs water in the gastrointestinal tract to increase stool bulk and promote bowel regularity.","indications":["Constipation relief","Bowel regularity maintenance","Irritable bowel syndrome symptom management"],"catalyst":""},{"name":"Standard interval dosing","genericName":"Standard interval dosing","slug":"standard-interval-dosing","phase":"marketed","mechanism":"Standard interval dosing is a dosing schedule approach rather than a drug itself, referring to the administration of medications at regular, fixed time intervals.","indications":[],"catalyst":""},{"name":"dexamethason","genericName":"dexamethason","slug":"dexamethason","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ertugliflozine","genericName":"ertugliflozine","slug":"ertugliflozine","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Benzbromaron","genericName":"Benzbromaron","slug":"benzbromaron","phase":"marketed","mechanism":"Eyes absent homolog 2, Eyes absent homolog 3, ATP-binding cassette sub-family G member 2","indications":["Gout","Hyperuricemia"],"catalyst":""},{"name":"Change in daily dosage of Growth Hormone","genericName":"Change in daily dosage of Growth Hormone","slug":"change-in-daily-dosage-of-growth-hormone","phase":"marketed","mechanism":"Growth hormone replacement therapy restores physiological growth hormone levels to promote normal growth, metabolism, and body composition.","indications":["Growth hormone deficiency in children","Growth hormone deficiency in adults","Short stature due to growth hormone insufficiency"],"catalyst":""},{"name":"Exenatide infusion","genericName":"Exenatide infusion","slug":"exenatide-infusion","phase":"phase_3","mechanism":"Exenatide is a GLP-1 receptor agonist that mimics glucagon-like peptide-1 to stimulate insulin secretion and reduce blood glucose in response to meals.","indications":["Type 2 diabetes mellitus (investigational infusion formulation)"],"catalyst":""},{"name":"Ferricarboxymaltose","genericName":"Ferricarboxymaltose","slug":"ferricarboxymaltose","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"GnRHa","genericName":"GnRHa","slug":"gnrha","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Lipiodol UltraFluid","genericName":"Lipiodol UltraFluid","slug":"lipiodol-ultrafluid","phase":"marketed","mechanism":"Lipiodol UltraFluid is an iodized poppy seed oil contrast agent that accumulates in hepatic lesions and provides both diagnostic imaging and therapeutic embolization.","indications":["Hepatocellular carcinoma (diagnostic imaging and transarterial chemoembolization)","Diagnostic imaging of liver lesions"],"catalyst":""},{"name":"Lopinavir/ritonavir + nevirapine","genericName":"Lopinavir/ritonavir + nevirapine","slug":"lopinavir-ritonavir-nevirapine","phase":"marketed","mechanism":"This combination inhibits HIV protease (lopinavir/ritonavir) and reverse transcriptase (nevirapine) to suppress viral replication.","indications":["HIV-1 infection"],"catalyst":""},{"name":"Lopinavir/ritonavir + zidovudine + lamivudine","genericName":"Lopinavir/ritonavir + zidovudine + lamivudine","slug":"lopinavir-ritonavir-zidovudine-lamivudine","phase":"marketed","mechanism":"This combination inhibits HIV reverse transcriptase and protease to suppress viral replication.","indications":["HIV-1 infection"],"catalyst":""},{"name":"Macrogol Only Product in Oral Dose Form","genericName":"Macrogol Only Product in Oral Dose Form","slug":"macrogol-only-product-in-oral-dose-form","phase":"marketed","mechanism":"Macrogol is an osmotic laxative that draws water into the intestinal lumen to soften stool and promote bowel movements.","indications":["Constipation (chronic and acute)","Bowel preparation prior to diagnostic procedures"],"catalyst":""},{"name":"Magnesium hydroxide 724mg","genericName":"Magnesium hydroxide 724mg","slug":"magnesium-hydroxide-724mg","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Placebo (for rivastigmine)","genericName":"Placebo (for rivastigmine)","slug":"placebo-for-rivastigmine","phase":"marketed","mechanism":"Placebo has no active pharmacological mechanism; it is an inert substance used as a control in clinical trials.","indications":["Control arm in rivastigmine clinical trials (Alzheimer's disease, Parkinson's disease dementia, or Lewy body dementia)"],"catalyst":""},{"name":"Prednisolone and Exenatide","genericName":"Prednisolone and Exenatide","slug":"prednisolone-and-exenatide","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Radium-223 chloride","genericName":"Radium-223 chloride","slug":"radium-223-chloride","phase":"phase_3","mechanism":"Radium-223 is an alpha-emitting radioisotope that mimics calcium and selectively targets bone metastases, delivering high-energy alpha particles directly to cancer cells in bone.","indications":["Metastatic castration-resistant prostate cancer with symptomatic bone metastases"],"catalyst":""},{"name":"Rhenium-188-HEDP","genericName":"Rhenium-188-HEDP","slug":"rhenium-188-hedp","phase":"phase_3","mechanism":"Rhenium-188-HEDP is a radiopharmaceutical that localizes to areas of increased bone metabolism and delivers beta radiation directly to bone lesions for pain palliation and potential therapeutic benefit.","indications":["Metastatic bone pain from osteoblastic bone lesions","Bone metastases in cancer patients"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE5qcVllU2x2UzdLeVhfb3ZraVo2Rk9CMHNqaW1ySVBfSTJzcDBCTEpoRlhvRmFJbi11cFdfYlhQREJQblB6QlhxeGZfa1U0bVVFUUJmZ1RZSUxjamE3TzVn?oc=5","date":"2025-09-30","type":"pipeline","source":"Nature","summary":"Challenges to determine synergistic drug interactions in mice - Nature","headline":"Challenges to determine synergistic drug interactions in mice","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE12UEZqVHEyR0NKWXE2STMtUklvMEFHMDJGYVhoem4xVC1yQkNVdk1BODBnbXQweTAzSEpicDkwSmVyZUxQMFh1OUJGRE5ZMGtOeFIzNzNLUnlhNnpzVHZaUlN0a1FhM3NzUGc?oc=5","date":"2024-12-12","type":"pipeline","source":"Neurology® Journals","summary":"Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis - Neurology® Journals","headline":"Association of the Cervical Canal Area With Disability and Progression in People With Multiple Sclerosis - Neurology® Jo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9HRkFtMWFjNVZyV0FwREgzVmQyWGpyWENOd3g1NGdPNV9sTFk4YmRoSjJhYmE2eU5ibWhwWUxRd3ozdkMxUFBPOURIY3FQX1NKU1FqeVJ6bl9YUUxVd3JXQTgyV3RoazhUYXc?oc=5","date":"2024-07-10","type":"pipeline","source":"Neurology® Journals","summary":"Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia - Neurology® Journals","headline":"Predicting Cognitive Decline in Amyloid-Positive Patients With Mild Cognitive Impairment or Mild Dementia - Neurology® J","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPTGtiR1lZZjFHUzFqNE16T1Z5SUlQUG9ONEI1T28zbHRZYU5wd3lIY2paR2MybkRlSVNWNXI2ZDNZRnlRUDNsekgzY3J0ak42Zy16UVI3NG9nemtWeDBSN292VXJHUi1CZ09TMkE1VDNJWEd6WGhoUjVsSUNrT0toc0F1QWYxa1pBTWxCRTlsU2pjVDBMZ3R6STk1ZFlFZUhvUmVBSzlWOWpzb3hraUVwT05aT2NwcWNGM2Nr?oc=5","date":"2024-04-01","type":"pipeline","source":"amsterdamumc.org","summary":"Joreintje Mackenbach new APH program leader Health Behaviors & Chronic Diseases - amsterdamumc.org","headline":"Joreintje Mackenbach new APH program leader Health Behaviors & Chronic Diseases","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFAxam9vSV9kNWwtMVJuQUJnS0VrZHB2VnRVOHVEUmRXYmNOdzZFdTBERUVuM2J1SE5vTDBneFR5OGJXNDNqQ3dkYWVIbFN1bTB4MDNjSXRTeGtabWxySGdr?oc=5","date":"2024-01-09","type":"pipeline","source":"Nature","summary":"Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct genetic risk profiles - Nature","headline":"Cerebrospinal fluid proteomics in patients with Alzheimer’s disease reveals five molecular subtypes with distinct geneti","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE5wTVlxckliWG9YQjliS1dmd2JGVUtZUWVJRTBJY2NqV0NVSzZ1bkhtNGxCWS1jMUNYSW1FcFBGc0RCdVlKUU4zV1lQd1FVLWlGQ1hhTU1sRmdNZDRiUjJKZk1JQ1psMzlueVpB?oc=5","date":"2023-12-26","type":"trial","source":"Wiley Online Library","summary":"Digital consults to optimize guideline-directed therapy: design of a pragmatic multicenter randomized controlled trial - Wiley Online Library","headline":"Digital consults to optimize guideline-directed therapy: design of a pragmatic multicenter randomized controlled trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxObUF6SmF0NWxfcWtWOS1CcE1SMUdmOUo2d1hWWGVjamtjaWhuSTl5bjRXSkcxSXlOeFBaRElPc1A0Q3R5dGZtWC1iem9OWjNiYXFHVEFZbjBKa1FmVFlMbXNTdmo5NHB0MGdnd281T3pLWE9ralpwMHRfQ0FYVlJsYnh2SHVVdFdMY0lOanJfbUN3MTc1TVFuSnAtTk0wVTYwbHBZQk1lZURWYVhfX1JBNHM1ZElndDZEU1JBQjduVHA?oc=5","date":"2023-12-11","type":"pipeline","source":"amsterdamumc.org","summary":"Metabolism - amsterdamumc.org","headline":"Metabolism","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMic0FVX3lxTE5IazVmRHE5ODF3bzZ0NGFtNjZNQ05hMjRSQi1LZFZ4WUlMcjktREpORVNabEJPWlM4RUwxZHNNenc0VEdSXzdNT203NVc3NkZtcC1jelJHVWdFNENEazFBSDNqVXZnWnhJZDQzdDM4RTgxRU0?oc=5","date":"2023-09-12","type":"pipeline","source":"Wiley","summary":"Acta Obstetricia et Gynecologica Scandinavica | NFOG Women's Health Journal | Wiley Online Library - Wiley","headline":"Acta Obstetricia et Gynecologica Scandinavica | NFOG Women's Health Journal | Wiley Online Library","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiakFVX3lxTE9hNzh3M3JrNWRwcXUzbUxfVm8zT203M3FwN3dhUzRSb0tkaVcyQjFFVkVucFowZl9qWU5CZmZmTlJ2bDhBd09HeUxOZEs2eW5ZRWVPSmxEc1BJTEY3UVRpRk5GaE9JMmt6LXc?oc=5","date":"2022-10-27","type":"trial","source":"Wiley Online Library","summary":"Patient experiences and views on pharmaceutical care during adjuvant endocrine therapy for breast cancer: A qualitative study - Wiley Online Library","headline":"Patient experiences and views on pharmaceutical care during adjuvant endocrine therapy for breast cancer: A qualitative ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPZnpTSzM3cWR6N3hveWVRdjlKNjlkYVNmTEtWdjhiNHdGdlYwN0RJOGtQSmFpNDlGUWxicE5kS0dLSTJCaGsyU0VPWDVRbEt2Qk1FMFRPbkprX3Zyc3QzZHo4MHVLN1dSc3dUcnNrMWRBR19na3dxVW04aHR4anRIeXBibllpSUlwajZOZDRuaU05WGZjajA1RGxKSURHTWNkdFdz?oc=5","date":"2021-06-01","type":"pipeline","source":"nwo.nl","summary":"Virtual human platform will eventually render animal experiments obsolete - nwo.nl","headline":"Virtual human platform will eventually render animal experiments obsolete","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1tYzlmbmpsMWN5RENSX3lXc2VueVlxLTh5aV9kZWlTczNIUFhlSlVZX1ZlcTNzOFJnNjItUl95ejNnaTJBUk1ISUJHS1ZlX0JZUGQtWnFFallLbmZGbjNTRWFKM3BSWXhSbExPRk5ITFpNbGE0OXc?oc=5","date":"2021-04-07","type":"pipeline","source":"MedPage Today","summary":"Guillain-Barre After COVID-19 Vaccine: Case Report - MedPage Today","headline":"Guillain-Barre After COVID-19 Vaccine: Case Report","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxNZ3E1MUF1cUhMdWJFX2d1N3o5TXYzVFhxS00wbEtIYUNjT2Q1VkpsSVVuaGtWdXUyNUdGZDZRNjRkNzhXXzZHa01idVlrNk8yVzZ2NFNBR2pOLUFqX25OdEpJX1VFQzQ5Q1NLWXNkRUlSTlNNVG8yX1dpMEZCNVVhTA?oc=5","date":"2020-01-10","type":"pipeline","source":"e-architect","summary":"Amsterdam UMC Imaging Center Building - e-architect","headline":"Amsterdam UMC Imaging Center Building - e","sentiment":"neutral"}],"patents":[],"drugCount":24,"phaseCounts":{"phase_2":3,"phase_1":2,"marketed":16,"phase_3":3},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}